• Academy Chapters
  • Psychiatry Studio
  • CME Academy
  • Blog
  • Pricing
  • Contact Us
    • Reviews
    Sign in

    Tag: MDD

    Severe Melancholic Depression: Diagnose & Treatment Options

    Melancholic depression is a severe subtype of major depressive disorder (MDD), often characterized by profound biological symptoms, significant functional impairment, and poor response to psychotherapy…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh April 16, 2025

    Spravato: First Monotherapy FDA Approved for Treatment-Resistant MDD

    Treatment-resistant depression (TRD) remains a significant challenge for clinicians and patients alike, often requiring innovative strategies beyond traditional antidepressants. A groundbreaking step in addressing this…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 25, 2025

    How to Dose Transdermal Selegiline for Treatment-Resistant MDD?

    Transdermal selegiline is a monoamine oxidase inhibitor (MAOI) used as a treatment option for patients with treatment-resistant major depressive disorder (MDD). Why Transdermal Selegiline preferred…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 7, 2024

    Atypical Antipsychotics for MDD Augmentation: Choosing the Right Option?

    When it comes to managing Major Depressive Disorder (MDD), the challenge often lies in patients who do not fully respond to first-line treatments like SSRIs…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 1, 2024

    Facebook Live 003: New Treatments in Pipeline

    Facebook LIVE 003: Join us for our third Facebook Live[May 18 at 10:30 am PST] Facebook LIVE is a new feature for our academy students.…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh May 15, 2024

    How to Dose Cariprazine for MDD Augmentation?

    Major depressive disorder (MDD) remains a significant global health challenge, affecting millions of individuals and often leading to substantial impairment in daily functioning. While a…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh March 18, 2024

    Gepirone (Exxua): New Antidepressant FDA Approved for MDD

    On Sep 28, 2023: Fabre-Kramer Pharmaceuticals Announcesd the FDA Approval of EXXUAâ„¢, the Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 30, 2023

    How to use Transdermal Selegiline for MDD?

    Monoamine Oxidase Inhibitors (MAOIs) have not only shown efficacy with treatment resistant depression, but are also found efficacious for the treatment of depression in the…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh July 28, 2023

     Trazodone Once-A-Day (TzOAD) for MDD?

    Trazodone belongs to a class of antidepressant medications called serotonin antagonists and reuptake inhibitors (SARIs). Traozodone is used more for insomnia treatment compared to MDD…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 16, 2023

    Persistent Complex Bereavement Disorder & Prolonged Grief Disorder

    As medical professionals, we are often tasked with helping our patients navigate the complexities of grief and loss. Losing a loved one is a deeply painful…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh April 21, 2023

    MDD Augmentation: S-Adenosyl Methionine (SAMe)

    We continue our lecture series “10 Augmentation Strategies for MDD” with our ninth lecture on the role of SAMe as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 28, 2023

    MDD Augmentation: Pramipexole

    We continue our lecture series “10 Augmentation Strategies for MDD” with our eighth lecture on the role of Pramipexole as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 26, 2023

    MDD Augmentation: Stimulants

    We continue our lecture series “10 Augmentation Strategies for MDD” with our sixth lecture on the role of Stimulants as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 22, 2023

    MDD Augmentation: Lamotrigine

    We continue our lecture series “10 Augmentation Strategies for MDD” with our fifth lecture on the role of Lamotrigine as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 21, 2023

    MDD Augmentation: L-MethylFolate

    We continue our lecture series “10 Augmentation Strategies for MDD” with our fourth lecture on the role of L-MethylFolate as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 19, 2023

    MDD Augmentation: Thyroid Hormone

    We continue our lecture series “10 Augmentation Strategies for MDD” with our third lecture on the role of thyroid hormine as an augmentation for major…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 15, 2023

    MDD Augmentation: Lithium

    We continue our lecture series “10 Augmentation Strategies for MDD” with our second lecture on the role of lithium as an augmentation for major depressive…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 15, 2023

    MDD Augmentation: Atypical Antipsychotics

    It is known that close to 50% of patients with major depressive episodes may not achieve remission after the trials of first-line antidepressants, and only…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 13, 2023

    Cariprazine: New FDA Indication for MDD Augmentation

    On Dec 16, 2022: AbbVie announced that FDA has approved Cariprazine as an adjunctive therapy to antidepressants for the treatment of major depressive disorder in…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh December 18, 2022

    Augmentation Strategies for Major Depressive Disorder

    PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MAJOR DEPRESSIVE DISORDER: 10 AUGMENTATION STRATEGIES Introduction Psychiatry Education Forum Academy continues to provide high-quality, evidence-based & practice-oriented discussions…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh December 17, 2022

    Single-Dose Psilocybin for a Treatment-Resistant Depression?

    Psychiatry Education Forum Academy is excited to announce the release of Academy’s 19th Journal Club discussion today: This article was published in the NEJM on…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh November 5, 2022

    Managing Treatment Resistant Depression with Atypical Features

    Depression with atypical features is defined as significant mood reactivity combined with two of the following clinical features: Hyperphagia Hypersomnia Leaden paralysis Pathological rejection sensitivity…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 14, 2022

    Can St. John’s Wort help with Depression?

    Psychiatry Education Forum Academy is excited to announce our next presentation’s release date for Sep 10, 2022: WATCH INTRODUCTION VIDEO https://youtu.be/Q01KwQTdTqM There are many plant-based…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 5, 2022

    Auvelity: New Oral Fast Acting FDA Approved Antidepressant

    On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh August 22, 2022

    Omega-3 Fatty Acids for Depression?

    Recently Omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) have drawn the clinical attention for the treatment of major depressive disorder. The…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh May 31, 2022

    How Long to Continue Antidepressants for MDD Treatment?

    Once you have initiated antidepressants for MDD (Major Depressive Disorder) treatment and the patient has achieved remission, how long will you continue this current antidepressant…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh November 1, 2021

    Treatment-Resistant MDD: Modafinil Augmentation

    Partial response, no response, or residual symptoms following antidepressant therapy is common in clinical psychiatry. Hence, it is of clinical importance to have knowledge of…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh September 21, 2021

    Journal Club #2: Omega-3 Fatty Acids for MDD Treatment (ISNPR Practice Guidelines)

    Today we posted the following second journal club in PEFA Journal Club’s discussion series: Journal Club #2: International Society for Nutritional Psychiatry Research Practice Guidelines…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 14, 2021

    Journal Club #1: Update on Nonpsychotic Unipolar Depression Management

    We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 13, 2021

    Medications vs Psychotherapy for MDD: Comparing 5 Major Guidelines

    How do you decide between psychotherapy versus medications for the treatment of major depressive disorder? Depression severity is one of the criteria used to make…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh May 8, 2021

    Join Academy Membership

    CME Academy

    Join Email Newsletter

    * indicates required

    Most Recent Posts

    • Sulforaphane for Negative Symptoms of Schizophrenia June 15, 2025
    • Low Dose Naltrexone for MDD Augmentation: What Clinicians Should Know June 14, 2025
    • Ranking Antidepressants for Adolescent Depression Based on New Meta-Analysis May 31, 2025
    • How to Diagnose Prescription Benzodiazepine Physical Dependence? May 24, 2025
    • Understanding Hoover Test: to Differentiate Functional vs. Organic Limb Weakness April 26, 2025
    • Severe Melancholic Depression: Diagnose & Treatment Options April 16, 2025
    • Antipsychotics-Induced Akathisia: 6 Evidence-Based Treatment Options March 29, 2025
    • Brexpiprazole + Sertraline: Could this be the next FDA-approved treatment for PTSD? March 3, 2025
    • Maintenance Treatment in Bipolar Depression: What Recent Data Reveals March 1, 2025
    • FDA Eliminates Clozapine REMS Program: What This Means for Patients and Prescribers February 25, 2025
    • Understanding Antidepressants’ Side Effects on Sleep: Sedation & Insomnia February 22, 2025
    • 📢 6th Live Academy’s Insight Session February 8, 2025
    • Psychotropics & Risk of Tinnitus February 6, 2025

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2025 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .